Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team. Wechsler ME, et al. Among authors: weller pf. N Engl J Med. 2017 May 18;376(20):1921-1932. doi: 10.1056/NEJMoa1702079. N Engl J Med. 2017. PMID: 28514601 Free PMC article. Clinical Trial.
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Steinfeld J, Bradford ES, Brown J, Mallett S, Yancey SW, Akuthota P, Cid MC, Gleich GJ, Jayne D, Khoury P, Langford CA, Merkel PA, Moosig F, Specks U, Weller PF, Wechsler ME. Steinfeld J, et al. Among authors: weller pf. J Allergy Clin Immunol. 2019 Jun;143(6):2170-2177. doi: 10.1016/j.jaci.2018.11.041. Epub 2018 Dec 19. J Allergy Clin Immunol. 2019. PMID: 30578883 Free PMC article. Clinical Trial.
Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features.
Dong ZM, Lin E, Wechsler ME, Weller PF, Klion AD, Bochner BS, Delker DA, Hazel MW, Fairfax K, Khoury P, Akuthota P, Merkel PA, Dyer AM, Langford C, Specks U, Gleich GJ, Chinchilli VM, Raby B, Yandell M, Clayton F. Dong ZM, et al. Among authors: weller pf. Am J Pathol. 2020 Jul;190(7):1438-1448. doi: 10.1016/j.ajpath.2020.03.005. Epub 2020 Apr 3. Am J Pathol. 2020. PMID: 32251643 Free PMC article.
The consequences of not having eosinophils.
Gleich GJ, Klion AD, Lee JJ, Weller PF. Gleich GJ, et al. Among authors: weller pf. Allergy. 2013 Jul;68(7):829-35. doi: 10.1111/all.12169. Epub 2013 Jun 6. Allergy. 2013. PMID: 23742015 Free PMC article. Review.
Eosinophils and disease pathogenesis.
Akuthota P, Weller PF. Akuthota P, et al. Among authors: weller pf. Semin Hematol. 2012 Apr;49(2):113-9. doi: 10.1053/j.seminhematol.2012.01.005. Semin Hematol. 2012. PMID: 22449621 Free PMC article. Review.
Eosinophilic pneumonias.
Akuthota P, Weller PF. Akuthota P, et al. Among authors: weller pf. Clin Microbiol Rev. 2012 Oct;25(4):649-60. doi: 10.1128/CMR.00025-12. Clin Microbiol Rev. 2012. PMID: 23034324 Free PMC article. Review.
Spectrum of Eosinophilic End-Organ Manifestations.
Akuthota P, Weller PF. Akuthota P, et al. Among authors: weller pf. Immunol Allergy Clin North Am. 2015 Aug;35(3):403-11. doi: 10.1016/j.iac.2015.04.002. Epub 2015 Jun 17. Immunol Allergy Clin North Am. 2015. PMID: 26209892 Free PMC article. Review.
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disorders.
Makiya MA, Khoury P, Kuang FL, Mata AD, Mahmood S, Bowman A, Espinoza D, Kovacs N, Brown T, Holland N, Wetzler L, Ware JM, Dyer AM, Akuthota P, Bochner BS, Chinchilli VM, Gleich GJ, Langford C, Merkel PA, Specks U, Weller PF, Wechsler ME, Prussin C, Fay MP, Klion AD. Makiya MA, et al. Among authors: weller pf. Allergy. 2023 Jan;78(1):258-269. doi: 10.1111/all.15481. Epub 2022 Sep 1. Allergy. 2023. PMID: 35971862 Free PMC article.
In Reply-Are Eosinophils Needed for Normal Health?
Wechsler ME, Ackerman SJ, Weller PF. Wechsler ME, et al. Among authors: weller pf. Mayo Clin Proc. 2022 Apr;97(4):805-807. doi: 10.1016/j.mayocp.2022.01.037. Mayo Clin Proc. 2022. PMID: 35379426 No abstract available.
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ; Mepolizumab HES Study Group. Rothenberg ME, et al. Among authors: weller pf. N Engl J Med. 2008 Mar 20;358(12):1215-28. doi: 10.1056/NEJMoa070812. Epub 2008 Mar 16. N Engl J Med. 2008. PMID: 18344568 Free article. Clinical Trial.
288 results